Multicentric Randomized Study of Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
Phase of Trial: Phase III
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis; Thrombosis
- Focus Therapeutic Use
- Acronyms RIPORT
- 03 Nov 2017 Planned End Date changed from 1 Sep 2020 to 1 Sep 2021.
- 03 Nov 2017 Planned primary completion date changed from 1 Sep 2019 to 1 Sep 2020.
- 21 Apr 2016 Status changed from recruiting to suspended.